ESSA Pharma Inc. (EPIX): Price and Financial Metrics


ESSA Pharma Inc. (EPIX): $8.59

-0.07 (-0.81%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

EPIX Stock Price Chart Interactive Chart >

Price chart for EPIX

EPIX Price/Volume Stats

Current price $8.59 52-week high $36.00
Prev. close $8.66 52-week low $5.40
Day low $8.33 Volume 116,934
Day high $8.71 Avg. volume 409,448
50-day MA $16.45 Dividend yield N/A
200-day MA $21.82 Market Cap 347.52M

ESSA Pharma Inc. (EPIX) Company Bio


ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on the development of novel and proprietary therapies for the treatment of prostate cancer. Its product candidate is EPI-506, an oral small molecule pro-drug that is in Phase 1/2 clinical trial, which blocks the N-terminal domain of the androgen receptor. The company was founded in 2009 and is based in Vancouver, Canada.


EPIX Latest News Stream


Event/Time News Detail
Loading, please wait...

EPIX Latest Social Stream


Loading social stream, please wait...

View Full EPIX Social Stream

Latest EPIX News From Around the Web

Below are the latest news stories about ESSA Pharma Inc that investors may wish to consider to help them evaluate EPIX as an investment opportunity.

ESSA Pharma to Present at Upcoming September Investor Conferences

ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced that David R. Parkinson, President and Chief Executive Officer of ESSA Pharma, will be presenting and hosting one-on-one meetings with investors at two upcoming virtual investor conferences. Peter Virsik, ESSA's Chief Operating Officer, and David S. Wood, ESSA's Chief Financial Officer, will also be availab

Yahoo | August 31, 2021

EPIX: Unwarranted Selloff Following Phase 1 Trial Update

By David Bautz, PhD NASDAQ:EPIX READ THE FULL EPIX RESEARCH REPORT Business Update Update on Phase 1 Trial of EPI-7386 ESSA Pharma Inc. (NASDAQ:EPIX) is currently conducting a Phase 1 clinical trial of EPI-7386 in patients with metastatic castration-resistant prostate cancer (mCRPC) who had progressed on two or more systemic therapies, including at least one second generation anti-androgen

Yahoo | August 24, 2021

Mid-Afternoon Market Update: Dow Turns Positive; Sesen Bio Shares Plummet

Toward the end of trading Monday, the Dow traded up 0.03% to 35,526.99 while the NASDAQ fell 0.34% to 14,771.91. The S&P also rose, gaining 0.02% to 4,468.88. The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 36,680,110 cases with around 621,630 deaths. India confirmed a total of at least 32,225,510 cases and 431,640 deaths, while Brazil reported over 20,364,090 COVID-19 cases with 569,050 deaths. In total, there were at least 207,273,290 cases of

Yahoo | August 16, 2021

Mid-Day Market Update: Crude Oil Down Over 2%; Travere Therapeutics Shares Jump

Midway through trading Monday, the Dow traded down 0.36% to 35,388.46 while the NASDAQ fell 1.24% to 14,639.36. The S&P also fell, dropping 0.54% to 4,443.76. The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 36,680,110 cases with around 621,630 deaths. India confirmed a total of at least 32,225,510 cases and 431,640 deaths, while Brazil reported over 20,364,090 COVID-19 cases with 569,050 deaths. In total, there were at least 207,273,290 cases of

Yahoo | August 16, 2021

Mid-Morning Market Update: Markets Open Lower; Empire State Manufacturing Index Dips In August

Following the market opening Monday, the Dow traded down 0.40% to 35,372.03 while the NASDAQ fell 1.27% to 14,634.24. The S&P also fell, dropping 0.57% to 4,442.47. The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 36,680,110 cases with around 621,630 deaths. India confirmed a total of at least 32,225,510 cases and 431,640 deaths, while Brazil reported over 20,364,090 COVID-19 cases with 569,050 deaths. In total, there were at least 207,273,290 ca

Yahoo | August 16, 2021

Read More 'EPIX' Stories Here

EPIX Price Returns

1-mo 10.70%
3-mo -68.44%
6-mo -72.22%
1-year 18.48%
3-year 162.69%
5-year N/A
YTD -28.00%
2020 116.91%
2019 161.90%
2018 -52.05%
2017 -90.00%
2016 -48.47%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 1.0701 seconds.